Hemostasis Today

November, 2026
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Syed Huzaifa Khan: Rethinking CTRP12 as a Biomarker for In Stent Restenosis
Oct 5, 2026, 12:41

Syed Huzaifa Khan: Rethinking CTRP12 as a Biomarker for In Stent Restenosis

Syed Huzaifa Khan, MBBS at Nowshera Medical College, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Clinical Cardiology, adding:

“Glad to share our recent publication.

‘Methodological Considerations in Evaluating CTRP12 as a Biomarker for In-Stent Restenosis’.

The paper highlights important considerations including potential selection/verification bias, lack of multivariable adjustment, and the possibility that early post-PCI CTRP12 levels may reflect acute vascular injury and inflammatory activation rather than processes specifically associated with subsequent restenosis.

The authors also discuss the need for appropriate adjustment of clinical and procedural factors and external validation before CTRP12 can be interpreted as an independent biomarker for in-stent restenosis.”

Title: Methodological Considerations in Evaluating CTRP12 as a Biomarker for In‐Stent Restenosis

Authors: Saleha Khattak, Syed Muhammad Rayyan, Syed Huzaifa Khan

Syed Huzaifa Khan: Rethinking CTRP12 as a Biomarker for In Stent Restenosis

Stay updated with Hemostasis Today.